SCHEMBL7984440

SCHEMBL7984440

CCc1nc(O)c2c(ncn2Cc2ccccc2F)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 6/20 0.40
PDE4B Q07343 6/20 0.40
PDE4C Q08493 6/20 0.40
PDE4D Q08499 6/20 0.40
PDE5A O76074 3/20 0.40
PDE1A P54750 3/20 0.40
PDE1B Q01064 3/20 0.40
PDE1C Q14123 3/20 0.40
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
LMNA P02545 3/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PKM P14618 2/20 0.38
PKLR P30613 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985554 0.92 SMN1; SMN2 (0.41) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7988782 0.87 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7974295 0.87 LMNA (0.40) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7988883 0.86 CYP11B1 (0.46) LMNATP53ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL7984394 0.86 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7975252 0.82 HPGD (0.45) POLBALDH1A1MEN1KMT2APKM
SCHEMBL7973917 0.81 LMNA (0.40) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7987222 0.81 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7984526 0.80 MET (0.46) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL7975222 0.79 MCL1 (0.39) PDE4APDE4BPDE4CPDE4DPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed